Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Long-term TENS treatment decreases cortical motor representation in multiple sclerosis.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.
A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city.
Recommendations for the management of multiple sclerosis relapses.
Major stressful life events in adulthood and risk of multiple sclerosis.
Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions.
Neuromuscular taping in multiple sclerosis. A pilot study.
Riluzole (2-amino-6-trifluoromethoxy benzothiazole) attenuates MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice.
Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event.
T cell vaccination in multiple sclerosis: results of a preliminary study.
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Effect of wearing a dorsiflexion assist orthosis on mobility, perceived fatigue and exertion during the six-minute walk test in people with multiple sclerosis: a randomised cross-over protocol.
Tangier's disease: An uncommon cause of facial weakness and non-length dependent demyelinating neuropathy.
Purified and synthetic Alzheimer's amyloid beta (Aβ) prions.
A randomized trial of stress management for the prevention of new brain lesions in MS.
[Inflammatory brain pseudotumor. A variant of demyelinating disease that simulates high-grade glioma].
Brain Region-specific Alterations in the Gene Expression of Cytokines, Immune Cell Markers and Cholinergic System Components During Peripheral Endotoxin-induced Inflammation.
"Putting One Foot in Front of the Other": A Qualitative Study of Emotional Experiences and Help-Seeking in Women with Multiple Sclerosis.
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
Non-lesional white matter changes in pediatric multiple sclerosis and monophasic demyelinating disorders.
The Brd4 acetyllysine-binding protein is involved in activation of polyomavirus JC.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Presymptomatic diagnosis with MRI and adequate treatment ameliorate the outcome after natalizumab-associated progressive multifocal leukoencephalopathy.
Capture, crawl, cross: the T cell code to breach the blood-brain barriers.
The dual S1PR1/S1PR5 drug BAF312 (Siponimod) attenuates demyelination in organotypic slice cultures.
Pages
« first
‹ previous
…
143
144
145
146
147
148
149
150
151
…
next ›
last »